IP Library Granted Patent US 7,157,616
Granted Patent B2
US 7,157,616 · App. 10/207,709 · Granted Jan 2, 2007

Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,157,616
App. No.
10/207,709
Granted
Jan 2, 2007
Kind
B2
Abstract

The invention is based on the discovery that certain variants of β-casein may induce Type-1 diabetes in susceptible individuals while other variants do not. The invention consists of the selection of non-diabetogenic milk producing cows and recovering and processing their milk and milk products. Another aspect of the invention is selectively breeding cows which produce the non-diabetogenic milk.

Claims (8)

1. A method for selecting cows whose milk is not diabetogenic to susceptible individuals which comprises determining the genotype of said cows and selecting those which produce non-diabetogenic milk which contains a β-casein variant with proline at amino acid position 67 and does not contain diabetogenic varients of β-casein which have a histidine at amino acid position 67.

2. A method for selecting bulls which produce daughters whose milk contains a β-casein variant with proline at amino acid position 67 which comprises determining the genotype of said bulls and selecting those whose daughters produce milk which contains a β-casein variant with proline at the 67 position.

3. The method as claimed in claim 1 wherein said cows are genotyped directly by using an appropriate probe and a polymerase chain reaction.

4. The method as claimed in claim 2 wherein semen from a bull being tested is genotyped directly by using an appropriate probe and a polymerase chain reaction.

5. The method as claimed in claim 1 wherein said β-casein variant is the A2 variant of non-diabetogenic β-casein.

6. The method as claimed in claim 2 wherein said β-casein variant is the A2 variant of β-casein.

7. The method as claimed in claim 1 wherein said β-casein variant is selected from the group consisting of the A3, D and E variants of non-diabetogenic β-casein.

8. The method as claimed in claim 2 wherein said β-casein variant is selected from the group consisting of the A3, D and B variants of β-casein.

Assignments (3)
CHANGE OF NAME Recorded Nov 13, 2014
From: A2 CORPORATION LIMITED
To: THE A2 MILK COMPANY LIMITED
Reel/Frame 034229/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2007
From: ELLIOTT, ROBERT B.; HILL, JEREMY P.
To: NATIONAL CHILD HEALTH RESEARCH FOUNDATION, THE; NEW ZEALAND DAIRY BOARD, THE
Reel/Frame 019061/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2007
From: NATIONAL CHILD HEALTH RESEARCH FOUNDATION, THE
To: A2 CORPORATION LIMITED
Reel/Frame 019061/0291 →
Priority Claims (1)
NZ 264862 · Apr 11, 1994 · national
Continuity (2)
Division 0883677800
Related Publication 20030017250A1 · Jan 23, 2003